Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cortesi

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Rays|April 28, 2005
Induction therapy before surgery for non-small cell lung cancerRoberta Ferraldeschi, Giuliana D'Auria, Adolfo De Pasquale Ceratti, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancerFilippo De Marinis, Maria Rita Migliorino, Luca Paoluzzi, et al.
Cancers|December 24, 2021
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective StudyMarta Tenuta, Alain Gelibter, Carla Pandozzi, et al.
Cells|May 16, 2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal CancerValentina Magri, Luca Marino, Chiara Nicolazzo, et al.
International Journal of Cancer|March 7, 2014
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancerPaola Gazzaniga, Ettore de Berardinis, Cristina Raimondi, et al.
Scientific Reports|August 25, 2016
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor NivolumabChiara Nicolazzo, Cristina Raimondi, MariaLaura Mancini, et al.
Anticancer Research|January 30, 2022
Intensified Total Neoadjuvant Therapy <i>Versus</i> Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching AnalysisFrancesca DE Felice, Daniela Musio, Franco Iafrate, et al.
Cancers|February 15, 2022
<i>RAS</i> Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based StudyChiara Nicolazzo, Francesca Belardinilli, Annarita Vestri, et al.
Cancers|July 29, 2023
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with SarcopeniaMarta Tenuta, Carla Pandozzi, Francesca Sciarra, et al.
European Radiology|August 18, 2022
Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancerFranco Iafrate, Fabio Ciccarelli, Giorgio Maria Masci, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Rays|April 28, 2005
Induction therapy before surgery for non-small cell lung cancerRoberta Ferraldeschi, Giuliana D'Auria, Adolfo De Pasquale Ceratti, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2003
Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancerFilippo De Marinis, Maria Rita Migliorino, Luca Paoluzzi, et al.
Cancers|December 24, 2021
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective StudyMarta Tenuta, Alain Gelibter, Carla Pandozzi, et al.
Cells|May 16, 2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal CancerValentina Magri, Luca Marino, Chiara Nicolazzo, et al.
International Journal of Cancer|March 7, 2014
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancerPaola Gazzaniga, Ettore de Berardinis, Cristina Raimondi, et al.
Scientific Reports|August 25, 2016
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor NivolumabChiara Nicolazzo, Cristina Raimondi, MariaLaura Mancini, et al.
Anticancer Research|January 30, 2022
Intensified Total Neoadjuvant Therapy <i>Versus</i> Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching AnalysisFrancesca DE Felice, Daniela Musio, Franco Iafrate, et al.
Cancers|February 15, 2022
<i>RAS</i> Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based StudyChiara Nicolazzo, Francesca Belardinilli, Annarita Vestri, et al.
Cancers|July 29, 2023
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with SarcopeniaMarta Tenuta, Carla Pandozzi, Francesca Sciarra, et al.
European Radiology|August 18, 2022
Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancerFranco Iafrate, Fabio Ciccarelli, Giorgio Maria Masci, et al.
Pageof 18